>
Budget Steak Tastes Like $100 After This One Trick
OPEC Fractures, the Draft Returns, and the Age of Consequences Begins
China Confirms Boeing Jet Deal, Agrees To Cut Select Levies & Expand Agri Trade
Here's Where Wealth Is Moving In America
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...
Cameco Sees As Many As 20 AP1000 Nuclear Reactors On The Horizon
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Mayo Clinic's AI Can Detect Pancreatic Cancer up to 3 Years Before Diagnosis–When Treatment...
A multi-terrain robot from China is going viral, not because of raw speed or power...
The World's Biggest Fusion Reactor Just Hit A Milestone
Wow. Researchers just built an AI that can control your body...
Google Chrome silently installs a 4 GB AI model on your device without consent
The $5 Battery That Never Dies - Edison Buried This 100 Years Ago

Now, researchers at the University of California, San Diego (UC San Diego) have tested a new approach to tackling congenital cataracts, turning to existing stem cells to repair the patient lenses post-surgery, restoring vision.
Current treatments for patients with congenital cataracts – a leading cause of blindness in children – is to extract the clouded lens, and implant an artificial lens to take its place. That procedure can be be dangerous, incurring significant risk to the patient in the form of potential pathogen transmission and immune rejection.
The alternative treatment that the researchers are working on approaches the problem from a different angle, looking not to replace the lens, but instead to make use of the regenerative potential of stem cells already present.